SWGRX Performance — Schwab Target 2015 Fund
Data updated: 2026-09-24
SWGRX returned +3.82% year to date and +9.42% over one year to Jul 2026. Annualised returns are +9.02% over 3 years and +4.07% over 5 years. The fund trailed its Target-Date category average: $100 invested three years ago grew to $130, against $146 for the category, and to $109 over one year, against $116. Volatility over the past three years was 7.19% a year. In the 12 months to Jul 2026 the fund lost a net $4.9M, and assets reached $41.45M.
SWGRX Growth of $100
What $100 invested in Schwab Target 2015 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | SWGRX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $109 | $116 |
| 3 years (Aug 2023 – Jul 2026) | $130 | $146 |
| 5 years (Aug 2021 – Jul 2026) | $122 | $142 |
| Since data start (Aug 2019 – Jul 2026) | $150 | $186 |
SWGRX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +3.82% |
| 1 year | +9.42% |
| 3 years (annualised) | +9.02% |
| 5 years (annualised) | +4.07% |
SWGRX Annual Returns
Calendar-year total returns of Schwab Target 2015 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +3.82% |
| 2025 | +11.82% |
| 2024 | +7.91% |
| 2023 | +12.46% |
| 2022 | −14.61% |
| 2021 | +7.50% |
| 2020 | +11.45% |
| 2019 (Aug–Dec) | +4.37% |
SWGRX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.2% | +1.4% | −3.5% | +3.7% | +1.7% | +0.1% | −0.7% | — | — | — | — | — |
| 2025 | +1.8% | +0.8% | −1.6% | +0.5% | +1.8% | +2.5% | +0.2% | +1.9% | +1.7% | +0.9% | +0.6% | +0.1% |
| 2024 | +0.2% | +1.2% | +1.8% | −2.9% | +2.8% | +1.2% | +2.1% | +1.8% | +1.4% | −2.0% | +2.5% | −2.1% |
| 2023 | +4.8% | −2.3% | +2.3% | +0.9% | −0.9% | +2.4% | +1.5% | −1.4% | −3.0% | −1.9% | +5.9% | +4.1% |
| 2022 | −3.3% | −1.9% | −0.6% | −5.1% | +0.3% | −4.5% | +4.6% | −3.3% | −6.2% | +2.4% | +4.9% | −2.3% |
| 2021 | −0.5% | +0.4% | +0.7% | +2.3% | +0.8% | +0.9% | +1.1% | +0.9% | −2.1% | +2.1% | −0.8% | +1.4% |
| 2020 | +0.5% | −2.1% | −6.3% | +5.7% | +2.5% | +1.5% | +2.8% | +2.2% | −1.2% | −1.1% | +5.2% | +2.0% |
| 2019 | — | — | — | — | — | — | — | +0.3% | +0.4% | +1.2% | +1.2% | +1.2% |
SWGRX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 7.19%
- 3-year Sharpe ratio: 0.63 (vs 4.5% risk-free rate)
- Best month: +5.93% (Nov 2023)
- Worst month: −3.46% (Mar 2026)
SWGRX Fund Flows
Monthly money in and out of Schwab Target 2015 Fund, from SEC Form N-PORT.
- 12-month net flow: −$4.9M
- 12-month gross sales (incl. reinvestments): $6.1M
- Sales ÷ redemptions: 0.55×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $41K | $448K | −$407K |
| Jun 2026 | $288K | $316K | −$28K |
| May 2026 | $149K | $4.5M | −$4.4M |
| Apr 2026 | $577K | $842K | −$265K |
| Mar 2026 | $79K | $202K | −$123K |
| Feb 2026 | $221K | $714K | −$493K |
| Jan 2026 | $480K | $1.2M | −$732K |
| Dec 2025 | $3.8M | $330K | $3.4M |
| Nov 2025 | $57K | $577K | −$519K |
| Oct 2025 | $167K | $686K | −$519K |
| Sep 2025 | $59K | $839K | −$780K |
| Aug 2025 | $201K | $345K | −$144K |
SWGRX Assets Under Management
Net assets of Schwab Target 2015 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $41.45M |
| 2026-04-30 | $45.77M |
| 2026-01-31 | $45.95M |
| 2025-10-31 | $46.71M |
| 2025-07-31 | $46.03M |
| 2025-04-30 | $49.11M |
| 2025-01-31 | $49.87M |
| 2024-10-31 | $48.61M |
| 2024-07-31 | $49.74M |
| 2024-04-30 | $49.41M |
| 2024-01-31 | $51.59M |
| 2023-10-31 | $49.40M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.